Results 101 to 110 of about 2,613 (178)

Early insights into viability of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak

The 2026 Bundibugyo virus disease (BVD) outbreak in the DRC and Uganda raises urgent questions about the efficacy of existing Ebola virus (EBOV) monoclonal antibodies (mAbs) against Bundibugyo virus (BDBV).
Daan Jansen, Stephen Balinandi, Pascal Adroba Tandele, Judith Kyokushaba, Prince Akil-Bandali, Miles Carroll, Hellen Rosette, Dieudonné Mwamba, Koen Vercauteren, Alisen Ayitewala, Daniel Kadobera, Piet Maes, Adrienne Amuri, Placide Mbala, Syrus Semawule, Andrew Nsawotebba, Steve Ahuka-Mundeke, Eilu Micheal, Charles Olaro, Martine Peeters, Eddy Kinganda-Lusamaki, Ahidjo Ayouba, Daudi Jjingo, Pierre Akilimali, Allan Niyonzima, Olivier Tshiani-Mbaya, Valeria Nakintu, Sabue Mulangu, Bernard Lubwama, Andrew Rambaut, Daniel Kyabayinze, Isaac Ssewanyana, Christian Ngandu, Henry Kyobe Bosa, Tony Wawina-Bokalanga, Stephen Kanyerezi, Gradi Luakanda-Ndelemo, Ronald Galiwango, Caroline Makoha, Daniel Euriene, Andrew Kambugu, Susan Nabadda, Jean-Jacques Muyembe-Tamfum, Andrew Walakira, Justus Nsio, Misaki Wayengera, Kevin Cissy Nabukeera, Servet Kimbonza, Diana Atwine, Sam Gidudu, Pontiano Kaleebu, Jean Nachega, Daniel Mukadi-Bamuleka, Atek Kagirita, Anne Rimoin, Aloysious Ssemaganda, Ronnie Bahatungire, Ibrahimm Mugerwa, Christian Happi, Laurens Liesenborghs, Jason Kindrachuk   +60 more
core   +1 more source

Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines

Abstract Background The ongoing Bundibugyo virus disease (BDBV) outbreak in Central Africa highlights the absence of approved vaccines specifically targeting BDBV. Whether licensed Zaire ebolavirus (EBOV) vaccines induce cross-reactive immunity against BDBV remains largely unknown.
Edouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, Safaa Ben-Farhat, Guillaume Thaurignac, Céline Roy, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh, Samba Sow, Stephen A Migueles, Deborah Watson-Jones, Yazdan Yazdanpanah, Rodolphe Thiébaut, Martine Peeters, Laura Richert, Yves Levy   +17 more
openaire   +1 more source

The Uganda – Democratic Republic of the Congo cross-border collaboration for Bundibugyo Ebola response: A new model for African health security, sovereignty and solidarity

Journal of Public Health in Africa
Henry K. Bosa, Pierre Z. Akilimali, Ingrid Ampeire, Atek Kagirita, Charles Olaro, Dieudonné Mwamba, Diana Atwine, Kasonde Mwinga, Christian Ngandu, Wessam Mankoula, Catherine A.H. Smallwood, Nebiyu Dereje, Marie-Roseline Belizaire, Yap Boum II, Mohamed Y. Janabi, Jean Kaseya, Chris Baryomunsi, Samuel R. Kamba   +17 more
doaj   +1 more source

Estimating the effectiveness of syndromic screening at airports for Bundibugyo ebolavirus disease

Abstract We used a stochastic simulation model to estimate the effectiveness of exit and/or entry syndromic screening at airports for Bundibugyo ebolavirus disease (BVD). For a 12-hour international flight from DRC or Uganda at 86% screening sensitivity, approximately 73% of infected people presenting for travel would
openaire   +1 more source

Reopening the discussion on Ebola virus nomenclature in the context of the 2026 Bundibugyo virus disease outbreak

In May 2026, the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Ebola virus outbreak caused by the Bundibugyo species in the Democratic Republic of the Congo and Uganda a public
Allan Komakech
core   +1 more source

Bundibugyo virus disease and the unfinished countermeasure agenda. [PDF]

Bull World Health Organ
Abrescia N, Capponi A, Maddaloni A, Molinaro G, D'Abbraccio M.   +4 more
europepmc   +1 more source

Public Information Demand During the 2026 Bundibugyo Virus Outbreak: A Dual Infodemiology Analysis Across Six Ebola Virus Disease Outbreaks. [PDF]

Viruses
Öztürk H, Aylı BI.
europepmc   +1 more source

Acceptability, feasibility and perceived benefits of integrating mental health and psychosocial support (MHPSS) into disease outbreak response in Western Uganda: a qualitative process evaluation study. [PDF]

BMJ Public Health
Yirdaw BA, Kalani K, Alkasaby M, Zhao Y, Wang L, Kwagala C, Mfitundinda E, Abbo C, Haque F, Eaton J.   +9 more
europepmc   +1 more source

Vaccine gaps in Bundibugyo ebolavirus outbreak control and their implications for global public health preparedness and response

The present study aims to critically examine recurrent Ebola virus disease (EVD) outbreaks—particularly Bundibugyo ebolavirus—with a focus on epidemiological trends, and gaps in vaccinology and public health preparedness, in order to inform concerted ...
Frank Adusei-Mensah
core   +1 more source

Bundibugyo virus disease evidence map: a rapid research needs appraisal. [PDF]

EClinicalMedicine
Sigfrid L, Spasenoska D, O'Dwyer S, de Swart M, Harriss E, Mendy T, Villanueva G, Henschke N, Norton A.   +8 more
europepmc   +1 more source